1. Home
  2. BGS vs LXEO Comparison

BGS vs LXEO Comparison

Compare BGS & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BGS

B&G Foods Inc.

HOLD

Current Price

$2.93

Market Cap

297.1M

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$4.08

Market Cap

348.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGS
LXEO
Founded
1996
2017
Country
United States
United States
Employees
86
N/A
Industry
Packaged Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
297.1M
348.7M
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
BGS
LXEO
Price
$2.93
$4.08
Analyst Decision
Hold
Strong Buy
Analyst Count
5
9
Target Price
$4.90
$18.44
AVG Volume (30 Days)
1.9M
645.2K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
14.34%
N/A
EPS Growth
83.02
39.81
EPS
N/A
N/A
Revenue
$1,828,687,000.00
$654,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.87
$3.99
52 Week High
$6.38
$10.99

Technical Indicators

Market Signals
Indicator
BGS
LXEO
Relative Strength Index (RSI) 26.91 33.74
Support Level N/A $4.01
Resistance Level $3.75 $5.38
Average True Range (ATR) 0.10 0.23
MACD -0.03 -0.06
Stochastic Oscillator 9.42 5.10

Price Performance

Historical Comparison
BGS
LXEO

About BGS B&G Foods Inc.

B&G Foods Inc manufactures, sells, and distributes a range of branded, shelf-stable, and frozen food and household products across the United States, Canada, and Puerto Rico. Its products include frozen and canned vegetables, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, and wine vinegar. The company's main brands include Crisco, Clabber Girl, Bear Creek, Polaner, Underwood, B&G, Grandma's, New York Style, B&M, Baker's Joy, Regina, TrueNorth, Static Guard, SugarTwin and Brer Rabbit. It operates in four reportable segments: i) Specialty, the majoriy revenue generating segment, ii) Meals, iii) Frozen & Vegetables, iv) Spices & Flavor Solutions.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Share on Social Networks: